UNSPSC 51201619: Rubella virus vaccine

This classification denotes a vaccine that addresses that acute infectious disease caused by the rubella virus, of type species of rubivirus causing acute infection in humans, primarily children and young adults, and which enters the respiratory tract via airborne droplet and spreads to the lymphatic system.

UNSPSC 51201619 Rubella virus vaccine is a Commodity code under which state and local health departments procure immunization products. The recent activity under this code shows a marked mismatch between the code's nominal scope and actual state procurement: the sole recent opportunity on record is the Mississippi State Department of Health's July 2026 sole source notice for Yellow Fever Vaccine from Sanofi Pasteur, Inc., not rubella vaccine. This signals either inconsistent code assignment in state purchasing systems or minimal recent rubella-specific procurement activity visible in public records. State health departments and their constituent vaccination programs are the primary issuing bodies under vaccine commodity codes; the Mississippi notice is the only recent solicitation available to evaluate.

The geographic spread of recent opportunities is heavily constrained: only Mississippi has posted a visible recent opportunity under this code as of mid-2026. The Mississippi State Department of Health sole source notice for Yellow Fever Vaccine closed August 3, 2026, with objections to sole source classification submitted to Cynthia Brasher at the state purchasing department. The notice did not specify quantity, contract term, estimated value, or pricing. Pursuit of opportunities under this code requires close attention to state health department RFQ and sole source activity, as procurement appears episodic and quantity-driven by seasonal immunization campaigns and inventory replenishment cycles rather than continuous demand.